In today’s briefing:
- Raffles Medical (RFMD SP) – Pivot in SG Travel Rules, Testing Regime and Its Implications
- Aussie Pharma (API AU): Scheme Booklet Out. Meeting On The 17 March
- Max Healthcare Institute Ltd | Q3FY22 Result Update
Raffles Medical (RFMD SP) – Pivot in SG Travel Rules, Testing Regime and Its Implications
- Singapore will apply streamlined COVID-19 rules from 25 February 2022, with a focus on vaccination status instead of an aggressive testing and surveillance regime
- We previously discussed how Raffles Medical benefits as the primary testing services provider at Changi airport and by facilitating Singapore’s vaccination drive
- Given the latest pivot in border protocols, and taking into account Singapore’s high vaccination rates, we discuss whether our initial investment hypothesis remains intact
Aussie Pharma (API AU): Scheme Booklet Out. Meeting On The 17 March
- Australian Pharmaceutical Industries (API AU)‘s Scheme Booklet is now out. The Scheme Meeting will be held on the 17 March with possible implementation on the 31 March.
- The Independent Expert has concluded this US$600mn Offer is fair and reasonable and in the best interest of Senex shareholders.
- The Offer price is full. And trading very tight to terms.
Max Healthcare Institute Ltd | Q3FY22 Result Update
- In-line performance with robust pickup in non-covid business.
Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.
Before it’s here, it’s on Smartkarma
